Literature DB >> 16270388

Separation of growth-stimulating peptides for Bifidobacterium from soybean conglycinin.

Wei-Yong Zuo1, Wei-Hua Chen, Si-Xiang Zou.   

Abstract

AIM: To isolate and identify the soybean conglycinin peptides that selectively stimulates the growth of bifidobacteria in vitro, and to investigate the effect of soybean conglycinin peptides on intestinal ecosystem in vivo.
METHODS: Soybean conglycinin was purified from soybean seeds by gel filtration (Sepharose-CL-6B). These proteins were submitted to hydrolysis by pepsin. Several growth-stimulating peptides for bifidobacteria were isolated chromatographically from pepsin hydrolysis of soybean conglycinin and identified by means of matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-MS). Parallel to in vitro study, in vivo experiments with soybean conglycinin peptides were performed in mice. Ninety male KM mice were randomly assigned into five groups of 16 mice each, and each group was administered for 21d intragastrically with physiological saline (control), conglycinin, pepsin-treated conglycinin (PTC), the most active fraction which isolated from pepsin-treated conglycinin (P2-PTC) and HCl-full hydrolysis of conglycinin (HCl-FHC), respectively. Intestinal microflora were evaluated by standard microbiologic methods and biochemical assays of cecal content samples after treatment.
RESULTS: The results showed that the peptides which were isolated from soybean conglycinin could stimulate the growth of bifidobacteria in vitro, and the molecular mass of purified peptides with MALDI-TOF-MS ranged from 693.32 to 1829.55. Compared with control group, in vivo experiments showed that P2-PTC group decreased cecal pH (7.08+/-0.08 vs 7.21+/-0.09, P<0.05) and enterococci counts (5.38+/-0.26 log10CFU/g vs 5.78+/-0.19 log10CFU/g, P<0.05), significantly increased sIgA level (172.08+/-35.40 ng/g vs 118.27+/-33.93 ng/g, P<0.01) and beta-galactosidase activity (1.28+/-0.23 U/g vs 1.82+/-0.58 U/g, P<0.05).
CONCLUSION: The results have shown that conglycinin is good source for enzyme-mediated production of peptides which stimulate the growth of bifidobacteria. These peptides are inactive within the sequence of the parent protein but can be released during enzymatic hydrolysis, and in vivo experiments demonstrate that conglycinin peptides may be beneficial for improving gastrointestinal health.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16270388      PMCID: PMC4479679          DOI: 10.3748/wjg.v11.i37.5801

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

Review 1.  Immunologic effects of yogurt.

Authors:  S N Meydani; W K Ha
Journal:  Am J Clin Nutr       Date:  2000-04       Impact factor: 7.045

Review 2.  Probiotics: potential pharmaceutical applications.

Authors:  Indu Pal Kaur; Kanwaljit Chopra; Amarpreet Saini
Journal:  Eur J Pharm Sci       Date:  2002-02       Impact factor: 4.384

Review 3.  Gut bacteria and health foods--the European perspective.

Authors:  M Saarela; L Lähteenmäki; R Crittenden; S Salminen; T Mattila-Sandholm
Journal:  Int J Food Microbiol       Date:  2002-09-15       Impact factor: 5.277

4.  The minimal nutritional requirements of Lactobacillus bifidus.

Authors:  J B HASSINEN; G T DURBIN; F W BERNHART
Journal:  J Bacteriol       Date:  1951-12       Impact factor: 3.490

5.  7S globulin from soybean is metabolized in human cell cultures by a specific uptake and degradation system.

Authors:  M R Lovati; C Manzoni; A Corsini; A Granata; R Fumagalli; C R Sirtori
Journal:  J Nutr       Date:  1996-11       Impact factor: 4.798

6.  Modification of the phosphoketolase assay for rapid identification of bifidobacteria.

Authors:  J I Orban; J A Patterson
Journal:  J Microbiol Methods       Date:  2000-05       Impact factor: 2.363

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea.

Authors:  P Brigidi; B Vitali; E Swennen; G Bazzocchi; D Matteuzzi
Journal:  Res Microbiol       Date:  2001-10       Impact factor: 3.992

Review 9.  Lactic acid bacteria and human clinical infection.

Authors:  M Aguirre; M D Collins
Journal:  J Appl Bacteriol       Date:  1993-08

10.  Molecular monitoring of succession of bacterial communities in human neonates.

Authors:  Christine F Favier; Elaine E Vaughan; Willem M De Vos; Antoon D L Akkermans
Journal:  Appl Environ Microbiol       Date:  2002-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.